[go: up one dir, main page]

IL39889A - Inhalers containing substances with anticholinergic activity and inhalers - Google Patents

Inhalers containing substances with anticholinergic activity and inhalers

Info

Publication number
IL39889A
IL39889A IL39889A IL3988972A IL39889A IL 39889 A IL39889 A IL 39889A IL 39889 A IL39889 A IL 39889A IL 3988972 A IL3988972 A IL 3988972A IL 39889 A IL39889 A IL 39889A
Authority
IL
Israel
Prior art keywords
composition
inhalant
ethyl
methobromide
inhaler
Prior art date
Application number
IL39889A
Other languages
English (en)
Hebrew (he)
Other versions
IL39889A0 (en
Original Assignee
Boehringer Sohn Ingelheim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Sohn Ingelheim filed Critical Boehringer Sohn Ingelheim
Publication of IL39889A0 publication Critical patent/IL39889A0/xx
Publication of IL39889A publication Critical patent/IL39889A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL39889A 1971-07-13 1972-07-12 Inhalers containing substances with anticholinergic activity and inhalers IL39889A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2134899A DE2134899C3 (de) 1971-07-13 1971-07-13 Verwendung von N-Äthyl-norscopolaminmethobromid

Publications (2)

Publication Number Publication Date
IL39889A0 IL39889A0 (en) 1972-09-28
IL39889A true IL39889A (en) 1976-05-31

Family

ID=5813500

Family Applications (1)

Application Number Title Priority Date Filing Date
IL39889A IL39889A (en) 1971-07-13 1972-07-12 Inhalers containing substances with anticholinergic activity and inhalers

Country Status (13)

Country Link
US (1) US4016279A (nl)
AU (1) AU470025B2 (nl)
BE (1) BE786200A (nl)
CA (1) CA988418A (nl)
DE (1) DE2134899C3 (nl)
FR (1) FR2145693B1 (nl)
GB (1) GB1392094A (nl)
HK (1) HK49679A (nl)
IE (1) IE36952B1 (nl)
IL (1) IL39889A (nl)
IT (1) IT1116880B (nl)
NL (1) NL175493C (nl)
ZA (1) ZA724724B (nl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4183912A (en) * 1978-01-16 1980-01-15 American Home Products Corporation Inhalation therapy for relieving bronchial spasm using quaternary salts of promethazine
IT1164227B (it) * 1983-05-13 1987-04-08 Angeli Inst Spa Composizione farmaceutica atta alla somministrazione nasale di sali quaternari d'ammonio ed attivita' anticolinergica
US4581225A (en) * 1984-04-25 1986-04-08 Eli Lilly And Company Sustained release intranasal formulation and method of use thereof
RU2684761C1 (ru) * 2018-02-20 2019-04-12 Федеральное государственное бюджетное образовательное учреждение высшего образования "Сибирский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ФГБОУ ВО СибГМУ Минздрава России) Способ профилактики респираторных осложнений у пациентов после хирургического лечения рака легкого

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2753288A (en) * 1953-01-12 1956-07-03 Upjohn Co Scopolamine lower-alkyl halide therapeutic composition
US3169095A (en) * 1962-10-30 1965-02-09 Rexall Drug Chemical Self-propelling powder-dispensing compositions
DE1670048C3 (de) * 1966-01-26 1980-09-04 C.H. Boehringer Sohn, 6507 Ingelheim Neue Norscopolaminderivate

Also Published As

Publication number Publication date
NL175493C (nl) 1984-11-16
CA988418A (en) 1976-05-04
BE786200A (fr) 1973-01-12
FR2145693A1 (nl) 1973-02-23
IE36952L (en) 1973-01-13
IT7949433A0 (it) 1979-06-15
ZA724724B (en) 1974-03-27
US4016279A (en) 1977-04-05
FR2145693B1 (nl) 1976-03-05
DE2134899A1 (de) 1973-02-01
HK49679A (en) 1979-07-27
NL7209675A (nl) 1973-01-16
IT1116880B (it) 1986-02-10
DE2134899C3 (de) 1981-04-02
DE2134899B2 (de) 1980-07-10
AU4449872A (en) 1974-01-17
AU470025B2 (en) 1976-03-04
NL175493B (nl) 1984-06-18
GB1392094A (en) 1975-04-23
IE36952B1 (en) 1977-03-30
IL39889A0 (en) 1972-09-28

Similar Documents

Publication Publication Date Title
RU2491072C2 (ru) Композиции для лечения легочной гипертензии, вводимые путем ингаляции, и способы их применения
AU775588B2 (en) Novel medicament compositions, based on anticholinergically effective compounds and beta-mimetics
JP4537652B2 (ja) 抗コリン作用薬及びシクレソニドをベースとする新規薬剤組成物
TNSN04149A1 (en) Pressurised metered dose inhalers containing solutions of beta-2 agonists
CA2628857A1 (en) Formulation and method for treating neoplasms by inhalation
WO2002083079A9 (en) Aerosol compositions containing formoterol for delivery to the lungs via nebulization
RU95112536A (ru) Способы пульсирующего системного введения активного фрагмента паратиреоидного гормона (ртн) и фармацевтические композиции, содержащие биологически активный n-концевой фрагмент паратиреоидного гормона (ртн)
SA04250122B1 (ar) دواء جديد يحتوي على العامل المساعد بيتا 2 شديد الفعالية وطويل المفعول وذلك بالاتحاد مع مكونات فعاله أخرى
US20040002548A1 (en) Medicament compositions containing anticholinergically-effective compounds and betamimetics
ES2292620T3 (es) Empleo de acido 13-cis retionico para el tratamiento de enfisema.
CN111936124A (zh) 一种含格隆铵盐及茚达特罗盐的气雾剂药物组合物及其制备方法与应用
EP0218679B1 (en) Aerosol compositions for nasal delivery of vitamin b 12
CN106667975A (zh) 一种吸入用异丙托溴铵溶液的制备方法
US9534007B2 (en) Methods and compositions for treatment of cyanide and hydrogen sulfide toxicity
IL39889A (en) Inhalers containing substances with anticholinergic activity and inhalers
MY137249A (en) Aerosol formulation for inhalation containing a tiotropium salt
CN107049674A (zh) 一种肢体临床护理的包扎换药装置
GB1333767A (en) Pharmaceutical compositions for inhalation comprising n-isopropyl noratropinium methylate salts
CN111971034A (zh) 一种含格隆铵盐的气雾剂药物组合物及其制备方法与应用
JP2002526435A (ja) 微小粉末薬剤
CN206651954U (zh) 一种肢体临床护理的包扎换药装置
Newman et al. Bronchodilator therapy with nebuhaler: how important is the delay between firing the dose and inhaling?
EP4475819A1 (en) Treprostinil iloprost combination therapy